McNeely Jennifer, Bradley Katharine A, Liebschutz Jane M, Subramaniam Geetha A
New York University Grossman School of Medicine, Dept. of Population Health, Section on Tobacco, Alcohol, and Drug Use, and Dept. of Medicine, Division of General Internal Medicine and Clinical Innovation; NIDA Clinical Trials Network New York Node, 180 Madison Ave., New York, NY 10016, United States of America.
Kaiser Permanente Washington Health Research Institute; University of Washington School of Medicine, Department of Medicine and Health Systems and Population Health; NIDA Clinical Trials Network Health Systems Node, 1730 Minor Ave, Suite 1360, Seattle, WA 98101, United States of America.
J Subst Use Addict Treat. 2025 Aug 8:209780. doi: 10.1016/j.josat.2025.209780.
While approximately one in five Americans with substance use disorder (SUD) receives treatment in addiction treatment programs, a majority have seen a primary care medical provider in the past year. Recognizing the critical role of primary care in addressing prevention and treatment of unhealthy substance use, for over a decade the National Drug Abuse Treatment Clinical Trials Network (CTN) has supported research to build the tools and evidence needed to support the integration of SUD care, while remaining realistic about the barriers to doing so. Authored by primary care and addiction medicine physician researchers, this commentary provides an overview of CTN primary care-focused research, from developing and implementing substance use screening tools to advancing evidence-based SUD treatment delivery in primary care settings. We identify three priority areas for research and practice innovations: 1) identifying effective treatment interventions to address polysubstance use; 2) improving screening and treatment for cannabis use; and 3) building the evidence base for substance use interventions among non-treatment seeking patients who have unhealthy drug use identified through screening. Addressing these areas can help primary care fulfill its potential as a key component of the substance use services continuum of care.
虽然约五分之一患有物质使用障碍(SUD)的美国人在成瘾治疗项目中接受治疗,但大多数人在过去一年里都看过初级保健医疗服务提供者。认识到初级保健在解决不健康物质使用的预防和治疗方面的关键作用,十多年来,国家药物滥用治疗临床试验网络(CTN)一直支持开展研究,以构建支持将SUD护理纳入其中所需的工具和证据,同时对这样做的障碍保持现实态度。这篇由初级保健和成瘾医学医师研究人员撰写的评论文章概述了CTN以初级保健为重点的研究,从开发和实施物质使用筛查工具到在初级保健环境中推进循证SUD治疗服务。我们确定了研究和实践创新的三个优先领域:1)确定有效的治疗干预措施以解决多物质使用问题;2)改善大麻使用的筛查和治疗;3)为通过筛查发现有不健康药物使用行为但未寻求治疗的患者建立物质使用干预的证据基础。解决这些领域的问题有助于初级保健发挥其作为物质使用服务连续护理关键组成部分的潜力。